Next Article in Journal
Characteristics of an In Vitro Mesenteric Lymph Node Cell Suspension Model and Its Possible Association with In Vivo Functional Evaluation
Next Article in Special Issue
Involvement of Fatty Acids and Their Metabolites in the Development of Inflammation in Atherosclerosis
Previous Article in Journal
Scaffolding of Mitogen-Activated Protein Kinase Signaling by β-Arrestins
Previous Article in Special Issue
Inflammation as A Precursor of Atherothrombosis, Diabetes and Early Vascular Aging
 
 
Review
Peer-Review Record

Exosome-Based Treatment for Atherosclerosis

Int. J. Mol. Sci. 2022, 23(2), 1002; https://doi.org/10.3390/ijms23021002
by Jeongyeon Heo 1 and Hara Kang 1,2,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2022, 23(2), 1002; https://doi.org/10.3390/ijms23021002
Submission received: 29 December 2021 / Revised: 14 January 2022 / Accepted: 14 January 2022 / Published: 17 January 2022

Round 1

Reviewer 1 Report

Overall it is a good review of exosome-based treatment for atherosclerosis. A minor spell check would be useful. Also, consider using a more general term "small extracellular vesicles (sEVs)" instead of exosomes according to the International Society of Extracellular Vesicles recommendations since exosomes are considered to be a subtype of sEVs. Some previous publications claim that they isolate Exosomes but according to the method they use for isolation it is more likely a mixture of small Extracellular Vesicles. 

Author Response

Reviewer 1

Overall it is a good review of exosome-based treatment for atherosclerosis. (1) A minor spell check would be useful. (2) Also, consider using a more general term "small extracellular vesicles (sEVs)" instead of exosomes according to the International Society of Extracellular Vesicles recommendations since exosomes are considered to be a subtype of sEVs. Some previous publications claim that they isolate Exosomes but according to the method they use for isolation it is more likely a mixture of small Extracellular Vesicles. 

Response:

(1) We did a spell check. We also found and corrected mistakes in the names of the three authors in sections 2 and 3. 

(2) We agreed with the comment by the reviewer. We explained that exosomes are nano-sized small extracellular membranous vesicles of 30–150 nm size in the Introduction of the original manuscript (line 35-37). In addition, in sections 2 to 4, we denoted extracellular vesicles or exosomes according to the nomenclature of original articles.

Reviewer 2 Report

The present work presents an interesting relationship between vesicles, their contents, and atherosclerosis.

It should be emphasized that it is a very preliminary proposal, perhaps the aspect of early diagnosis rather than treatment could be emphasized.

In addition, I believe it would be useful to have a summary table with miRNAs and their possible regulatory effect, in particular on the anti-inflammatory and antioxidant action.

Author Response

Reviewer 2

The present work presents an interesting relationship between vesicles, their contents, and atherosclerosis.

  1. It should be emphasized that it is a very preliminary proposal, perhaps the aspect of early diagnosis rather than treatment could be emphasized.

Response: We agreed with the comment by the reviewer. We mentioned that recent studies have begun to focus on the use of exosomes as therapeutic tools in the discussion.

 

  1. In addition, I believe it would be useful to have a summary table with miRNAs and their possible regulatory effect, in particular on the anti-inflammatory and antioxidant action.

Response: We agreed with the comment by the reviewer. A summary table of exosomal miRNAs with anti-atherosclerotic effects was added (Table 1).

Back to TopTop